Hematologists Accepting UnitedHealthcare in Massachusetts

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Paul Richardson, MD

Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.

Hematology

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Jorge Castillo, MD

Associate Professor at Harvard Medical School, an Institute Physician at the Dana-Farber Cancer Institute, and the Clinical Director of the Bing Center for Waldenström M; Director of the WM-NET, a consortium composed of academic researchers in the United States focused on designing and executing clinical research in patients wi

Hematology

Thomas Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology; Chair, Department of Dermatology, Brigham and Women's Hospital

Hematology

Judy Garber, M.D.

Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.&nb

Hematology

David Reardon, MD

Clinical Director, Center for Neuro-Oncology

Hematology

Andrew Brunner, M.D.

Hematology

Tracy Batchelor, MD MPH

Hematology

Glenn Hanna, M.D.

Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff

Hematology

Amir Fathi, M.D.

Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital

Hematology

Andrew Yee, M.D.

Hematology

Ronald Takvorian, MD

Assistant Professor of Medicine, Harvard Medical School

Hematology

Matthew Frigault, MD

Hematology

Panagiotis Konstantinopoulos, M.D.

Director of the Mellen and Eisenson Family Center for BRCA and Related Genes and Director of Translational Research, Division of Gynecologic Oncology. He is a; Chair for Clinical and Translational Research at DFCI and Professor of Medicine at Harvard Medical School. His clinical and translational research career f

Hematology

Matthew Davids, M.D.

Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and a; Director, Clinical Research, Division of Lymphoma

Hematology

Gregory Abel, MD

Director, Older Adult Hematologic Malignancy Program; Senior Physician

Hematology

Kimmie Ng, MD

Professor of Medicine at Harvard Medical School, Associate Chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute (DFCI), and the F; Director of the Young-Onset Colorectal Cancer Center at DFCI. Her research focuses on identifying dietary and molecular predictors of colorectal cancer risk a

Hematology

Caron Jacobson, MD

Director, Immune Effector Cell Therapy Program; Senior Physician

Hematology